secwatch.observer — SEC 8-K summary
======================================

Issuer:     YIELD10 BIOSCIENCE, INC. (—)
CIK:        0001121702
Form:       8-K
Filed at:   2024-02-16T23:59:59+00:00
Accession:  0001121702-24-000012
Event type: regulatory
Sentiment:  negative
Materiality: 0.82
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Yield10 Bioscience granted Nasdaq extension until May 13, 2024, subject to conditions
--------------------------------------------------------------------------------

- Panel granted extension to May 13, 2024, after Feb 6 hearing; conditions include a written financing update by Mar 15.
- Company remains non-compliant with minimum stockholders' equity and $1.00 bid price requirements on Nasdaq.
- Bid price compliance period ends Mar 25, 2024; may seek additional 180-day period if not met.
- No assurance that Yield10 can satisfy ongoing listing criteria during the extension period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1121702/000112170224000012/0001121702-24-000012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1121702/000112170224000012/yten-20240213.htm
  HTML page:      https://secwatch.observer/filing/0001121702-24-000012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer